DUOPHARMA BIOTECH BERHAD

KLSE (MYR): DPHARMA (7148)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

1.25

Today's Change

-0.01 (0.79%)

Day's Change

1.24 - 1.25

Trading Volume

99,500

Financial

Show?
Last 10 FY Result
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 826,698 787,525 704,727 696,717 639,175 569,902 576,462 498,722 467,987 312,940 270,680 176,961 16.58%
PBT 83,441 69,615 63,267 84,851 82,983 76,157 70,809 59,666 51,796 31,479 49,755 46,509 3.47%
Tax -20,025 -13,552 -10,622 -14,739 -17,300 -17,547 -15,536 -12,025 -9,696 -4,653 0 0 -
NP 63,416 56,063 52,645 70,112 65,683 58,610 55,273 47,641 42,100 26,826 49,755 46,509 1.38%
-
NP to SH 63,416 56,063 52,645 70,112 65,683 58,610 55,273 47,641 42,492 27,115 38,775 35,271 4.54%
-
Tax Rate 24.00% 19.47% 16.79% 17.37% 20.85% 23.04% 21.94% 20.15% 18.72% 14.78% 0.00% 0.00% -
Total Cost 763,282 731,462 652,082 626,605 573,492 511,292 521,189 451,081 425,887 286,114 220,925 130,452 19.56%
-
Net Worth 692,598 692,598 682,979 657,045 621,564 642,484 525,364 483,173 479,809 454,703 270,177 192,942 15.06%
Dividend
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Div 12,825 26,934 22,124 21,901 21,660 45,891 40,937 36,403 23,711 18,132 15,843 25,679 -1.64%
Div Payout % 20.23% 48.04% 42.03% 31.24% 32.98% 78.30% 74.06% 76.41% 55.80% 66.87% 40.86% 72.81% -
Equity
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Net Worth 692,598 692,598 682,979 657,045 621,564 642,484 525,364 483,173 479,809 454,703 270,177 192,942 15.06%
NOSH 961,942 961,942 961,942 952,239 941,765 706,026 684,383 661,881 278,959 278,959 278,959 138,807 23.98%
Ratio Analysis
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 7.67% 7.12% 7.47% 10.06% 10.28% 10.28% 9.59% 9.55% 9.00% 8.57% 18.38% 26.28% -
ROE 9.16% 8.09% 7.71% 10.67% 10.57% 9.12% 10.52% 9.86% 8.86% 5.96% 14.35% 18.28% -
Per Share
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 85.94 81.87 73.26 73.17 67.87 80.72 84.49 75.35 167.76 112.18 162.30 127.49 -5.96%
EPS 6.59 5.83 5.49 7.39 6.98 8.46 8.25 7.26 15.09 9.62 19.17 25.41 -15.64%
DPS 1.33 2.80 2.30 2.30 2.30 6.50 6.00 5.50 8.50 6.50 9.50 18.50 -20.66%
NAPS 0.72 0.72 0.71 0.69 0.66 0.91 0.77 0.73 1.72 1.63 1.62 1.39 -7.18%
Adjusted Per Share Value based on latest NOSH - 961,942
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 85.94 81.87 73.26 72.43 66.45 59.24 59.93 51.85 48.65 32.53 28.14 18.40 16.58%
EPS 6.59 5.83 5.49 7.29 6.83 6.09 5.75 4.95 4.42 2.82 4.03 3.67 4.57%
DPS 1.33 2.80 2.30 2.28 2.25 4.77 4.26 3.78 2.46 1.88 1.65 2.67 -1.64%
NAPS 0.72 0.72 0.71 0.683 0.6462 0.6679 0.5461 0.5023 0.4988 0.4727 0.2809 0.2006 15.06%
Price Multiplier on Financial Quarter End Date
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 30/09/24 30/09/24 29/12/23 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 -
Price 1.36 1.36 1.26 1.61 1.68 3.38 1.42 0.95 2.53 1.98 2.62 2.50 -
P/RPS 1.58 1.66 1.72 2.20 2.48 4.19 1.68 1.26 1.51 1.76 1.61 1.96 -1.43%
P/EPS 20.63 23.34 23.02 21.87 24.09 40.72 17.53 13.20 16.61 20.37 11.27 9.84 9.89%
EY 4.85 4.29 4.34 4.57 4.15 2.46 5.70 7.58 6.02 4.91 8.87 10.16 -9.01%
DY 0.98 2.06 1.83 1.43 1.37 1.92 4.23 5.79 3.36 3.28 3.63 7.40 -14.37%
P/NAPS 1.89 1.89 1.77 2.33 2.55 3.71 1.84 1.30 1.47 1.21 1.62 1.80 -0.18%
Price Multiplier on Announcement Date
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 08/11/24 08/11/24 22/02/24 23/02/23 15/02/22 22/02/21 13/02/20 18/02/19 28/02/18 24/02/17 23/02/16 24/02/15 -
Price 1.25 1.25 1.21 1.65 1.60 3.42 1.64 1.03 2.97 2.23 2.61 2.92 -
P/RPS 1.45 1.53 1.65 2.26 2.36 4.24 1.94 1.37 1.77 1.99 1.61 2.29 -3.57%
P/EPS 18.96 21.45 22.11 22.41 22.94 41.20 20.24 14.31 19.50 22.94 11.23 11.49 7.53%
EY 5.27 4.66 4.52 4.46 4.36 2.43 4.94 6.99 5.13 4.36 8.91 8.70 -7.01%
DY 1.07 2.24 1.90 1.39 1.44 1.90 3.66 5.34 2.86 2.91 3.64 6.34 -12.52%
P/NAPS 1.74 1.74 1.70 2.39 2.42 3.76 2.13 1.41 1.73 1.37 1.61 2.10 -2.31%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
13 people like this. Showing 50 of 12,449 comments

stevenckheng

noob company slowly moving a way from pharmaceutical

2023-09-06 20:25

teknikal

Support at RM1.10, if broken then RM1 is the next support

2023-09-11 09:17

fortunefire

parking here. tp 0.9x

2023-09-11 11:08

chkhooju

Moving up nicely.

2023-09-11 12:51

BobAxelrod33

Managed and operated by white haired people sitting in wheel chairs and using walking sticks. Most have prostate problems, waking few times at night to urinate. Some are waiting for stairways to Heavens........HOW COULD COMPANY BE AGGRESSIVE???

2023-10-08 13:10

MrFox

fruitcake becimes mouldy!!

2023-11-09 11:38

MagicalBobby

3Q23 profits down 45% YoY....current BOD is a team of silver haired centennials in wheelchairs. Raising 2 Billion bonds for retirement benefits?

BOD too aggressive is bad, weak BOD is also bad.......take your pick.

2023-11-10 12:07

Apastock

mari mari 1.50 yihaa ....

2023-11-10 12:55

BobAxelrod6868

You'd be lucky to even break 1.40.......

2023-11-21 07:47

BobAxelrod33

Pharma is dying, yet this ctnr with Management in wheelchairs cannot take advantage.

2023-12-02 09:04

BobAxelrod33

Max speed 2 mph......take your pick.

2023-12-04 15:13

Jettson8

not yet, it will make good performance in Q4

2023-12-06 16:38

Jettson8

it starts rebounding 😀 up up up

2023-12-15 15:38

NoTimeToTrade

This is just reaction to Covid case spike, after that fall back down. Nothing new and exciting on the horizon for pharma in the coming months especially when Pharmaniaga still in the dump and government cutting back on spending.

2023-12-15 16:03

Liner8

Great upup

2023-12-16 06:54

143922

3.00 is coming

2023-12-16 12:49

Jettson8

Dpharma is more stable and solid than those companies, fruitcake

2023-12-24 09:46

143922

Jual je la sykt GLC ni.epf pun tak mau beli ticket.kannaya

2023-12-31 09:31

Jettson8

Hope this collaboration can bring good revenue to the company for Fy2024 and so on

https://theedgemalaysia.com/node/692365

2024-01-15 17:14

100Mark

See, Kwsp was buying in. I think it can 😄

2024-01-22 17:34

Jettson8

Ya, even TA securities raised its target price to Rm1.47

2024-01-26 15:41

100Mark

Duopharma Biotech Bhd is likely to see a recovery in its consumer healthcare (CHC) segment, while sales to the government sector is also expected to increase in 2024.

https://www.thestar.com.my/business/business-news/2024/01/26/duopharma-earnings-set-to-improve-this-year

2024-01-30 17:36

100Mark

@metaverse. What did you use for that technical analysis?

2024-02-02 16:19

MrFox

fruitcake turns mouldy?

2024-02-21 11:40

Meshach Mano

Starting its journey to 1.4 soon

2024-05-01 18:43

cyberzigot

Limit up

2024-05-02 09:08

Mar2083

Afternoon sessions limit up
Huat ar

2024-05-02 09:12

NoTimeToTrade

Duopharma Biotech Clinches MYR578 million Supply Deals

https://www.tradingview.com/news/mtnewswires.com:20240501:G2361746:0/

2024-05-02 09:21

jenabchen123

Yuhoo!!! Finally Duo making big move. 1.40 seems reasonable figure to relief breath.

2024-05-02 19:09

Mar2083

Potentially may test 1. 4 tomorrow

2024-05-02 21:53

jenabchen123

Ayo!!! What has 600m contract do to the Duo's share price??? Sometime the illogical happen.....

2024-05-04 18:39

Jettson8

or you are more fond of pharmaniaga, fruitcake 😁

2024-06-11 20:33

Jettson8

That is 1-year low price for Dpharma dude

fruitcake

1.10 please

19 hours ago

2024-06-14 11:03

Jettson8

A+ for your patience 😆

2024-06-19 17:12

NoTimeToTrade

Haha unfortunately i'm closing my position with Dpharma, feels like watching paint dry. Anyways good luck guys.

2024-06-26 11:32

Jettson8

I am pretty sure you made a good profit from it, NoTimeToTrade 😉

2024-06-28 17:16

100Mark

Oww...EPF is throwing this moth

2024-07-09 18:10

100Mark

EPF switched to another counters like CTOS, KLK, ...

2024-07-15 16:46

Jettson8

no worries, Duopharma still hanging strong

2024-07-18 12:17

fruitcake

will be very hard for dumpharma to go beyond here this year. believe me😁

2024-07-29 16:44

100Mark

Ya, it will only move back and forth at 1.20 - 1.30

2024-07-29 22:02

fruitcake

testing 1.20. bearish indicators. run or no run😱

2024-07-30 10:10

100Mark

IF urgently need the money, then better run

2024-07-30 23:21

100Mark

The market will become very 'interesting' tmr

2024-08-04 12:35

Jettson8

Duopharma Biotech 2Q net profit up 33%, pays one sen dividend 🔥

https://theedgemalaysia.com/node/722957

2024-08-16 11:40

100Mark

It will move up after 12 Sep 🤓

2024-08-30 17:10

100Mark

Time for Dpharma to wake up

1 week ago

Post a Comment